NCT04070833View on ClinicalTrials.gov

Effects of Vitamin D and Omega-3 on Cerebrovascular Disease

NACompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

September 17, 2018

Study Completion Date

September 17, 2018

Conditions
StrokeVitamin D
Interventions
DIETARY_SUPPLEMENT

Vitamin D

Dietary Supplement: Vitamin D-3 (cholecalciferol), 2000 IU Other Name: cholecalciferol

DRUG

Fish oil

Drug: Omega-3 fatty acids (fish oil) Omacor, 1 capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \[EPA\] and 375 mg of docosahexaenoic acid \[DHA\])

DIETARY_SUPPLEMENT

Vitamin D placebo

Vitamin D placebo

DRUG

Fish oil placebo

Fish oil placebo

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT04070833 - Effects of Vitamin D and Omega-3 on Cerebrovascular Disease | Biotech Hunter | Biotech Hunter